1045-16: Pharmacogenomics Nursing: Personalized Health Care

4.09 (11 votes)

Recorded On: 10/19/2016

1045-16: Pharmacogenomics Nursing: Personalized Health Care

Pharmacogenomics nursing is about the relationship between an individual's genes and drug response. Nurses already use knowledge about drug to drug interactions to promote safe, efficacious medication outcomes. Pharmacogenomics takes this knowledge a step further by matching a drug treatment to a patient's genotype.

Presenter: Julie Anne Follett, MSN, PMHCNS-BC

Disclosures:  The presenter discloses involvement with Speaker Bureau: Assurex Health. Off-label uses will be discussed during this presentation.

Session Length:  1 Hour 45 minutes

Target Audience:  RN, APRN

Session Objectives
Upon completion of this presentation, the participant will be able to:
1.  Describe pharmacogenomics nursing.
2.  Identify one pharmacogenomics nursing practice they can implement upon return to work.
3.  State a significant impact pharmacogenomics nursing will have on the future of patient care.

Keywords: Pharmacogenomics, Genomics, Personalized Medicine

Continuing Nursing Education
1.75 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date.  You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass.  Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately.  You cannot earn credit unless all steps are completed. 

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Originally Presented
APNA 30th Annual Conference
Hartford, Connecticut
Wednesday, October 19
3:30pm - 5:30pm 

Release Date: December 16, 2016
The contact hours for this session expire:  November 30, 2019

 

Components visible upon registration.